Estimating the impact of improved management of haemophilia a on clinical outcomes and healthcare utilisation and costs.

Objective: Haemophilia A (HA) is associated with high clinical and healthcare burden. We developed an Excel-based model comparing current practice to improved management in severe HA patients currently managed on demand (OD). Outcomes included short- and long-term bleed events.